Editas Medicine Inc (EDIT) concluded trading on Thursday at a closing price of $1.83, with 7.76 million shares of worth about $14.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -53.32% during that period and on February 27, 2025 the price saw a loss of about -0.54%. Currently the company’s common shares owned by public are about 82.54M shares, out of which, 81.78M shares are available for trading.
Stock saw a price change of -11.17% in past 5 days and over the past one month there was a price change of 28.87%. Year-to-date (YTD), EDIT shares are showing a performance of 44.09% which decreased to -77.30% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.12 but also hit the highest price of $11.58 during that period. The average intraday trading volume for Editas Medicine Inc shares is 3.99 million. The stock is currently trading 15.09% above its 20-day simple moving average (SMA20), while that difference is up 28.47% for SMA50 and it goes to -46.17% lower than SMA200.
Editas Medicine Inc (NASDAQ: EDIT) currently have 82.54M outstanding shares and institutions hold larger chunk of about 62.87% of that.
The stock has a current market capitalization of $151.06M and its 3Y-monthly beta is at 1.88. It has posted earnings per share of -$2.56 in the same period. It has Quick Ratio of 3.75 while making debt-to-equity ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EDIT, volatility over the week remained 18.89% while standing at 16.81% over the month.
Stock’s fiscal year EPS is expected to drop by -33.69% while it is estimated to increase by 48.37% in next year. EPS is likely to grow at an annualized rate of 15.23% for next 5-years, compared to annual growth of 2.88% made by the stock over the past 5-years.
Stock get an Equal weight rating from Wells Fargo on December 11, 2024.
